Board documents - Unitaid

⚲Search

English

Apply for funding

Who we are
Who we are
Learn more about our work and how we help accelerate the global health response.
About Unitaid
Strategy

Our organization

Work with us
What we do
What we do
Focus areas

HIV & coinfections

Tuberculosis

Malaria

Women's & children's health

Global health emergencies
Oxygen

Regional manufacturing

Climate and health

Cross-cutting priorities
Investments

Explore how our investments are shaping disease responses.
Learn more

Apply for funding

Financial grants to accelerate innovation in global health.
Learn more
Our impact

Our impact

Why Unitaid?

Learn more about the difference our work makes in the lives of people in low- and middle-income countries.
Learn more

Evaluations

External evaluations provide independent assessments of our work.

Learn more

Game-changing innovations

Explore the technologies and interventions we're working on.

Learn more
News & Events

News & events

News

All news News releases Stories Opinions Videos

In the media

See where our work is being mentioned in the media world.
Learn more

Press center

Resources for journalists and media representatives.
Learn more

All news

Call for PRC membership applications – February 2025

Unitaid remains committed to equitable access to critical health innovations

Spotlighting women’s health at the World Economic Forum

Learn more

News releases

Call for PRC membership applications – February 2025

New vector control tool effectively reduces malaria transmission in major clinical trial

Unitaid and Gavi establish new partnership to improve access to cervical cancer prevention  

Learn more

Stories

The last mile in child medicine: The best HIV medicines for the youngest babies

Kenya pioneers a new tool in the fight against malaria

From principle to practice: Involving communities in research design for effective hepatitis C prevention

Learn more

Opinions

Unitaid’s Early Market Access Vehicle – an innovative demand-driven model to catalyze introduction of new optimal health products in low- and middle-income countries

From promise to impact: Unlocking lenacapavir’s potential to end HIV

With antimicrobial resistance, women and children face highest risks

Learn more

Videos

Spotlighting women’s health at the World Economic Forum

Sally’s story: One woman’s fight against cervical cancer

COP29 spotlight: How Unitaid can reduce emissions in HIV treatment

Learn more
Publications

⚲

Board documents

Board meeting document
e-Resolutions
Key governance documents

19-20 December 2017

Board Meeting 28

Starling Hotel Geneva, Switzerland.

Minutes:

Resoultions:

R1 - Replenishment of Unitaid’s Proposal Review Committee

R2 - Adoption of the Terms of Reference of the Proposal Review Committee (PRC)

R3 - Approval of the 2018 Unitaid budget

R4 - Unitaid Commitment Policy

R5 - Fever Management Area for Intervention

R6 - Governance Working Group Extension of Mandate

R7 - Appointment of PSC and FAC members

07-08 June 2017

Board Meeting 27

Starling Hotel Geneva, Switzerland.

Minutes:

Resoultions:

R1 - Better tools for integrated management of childhood fever

R2 - Amended Terms of Reference of the Policy and Strategy Committee

R3 - Amended Terms of Reference for the Proposal Review Committee

R4 - Unitaid 2016 Audited Financial Statements

R5 - Area for Intervention: Optimizing management of coinfections and comorbidities in people living with HIV

13-14 December 2016

Board Meeting 26

Starling hotel Geneva, Switzerland.

Minutes:

Resoultions:

R1 - Unitaid Strategy 2017-2021

R2 - Strategy 2017-2021: Key Performance Indicators

R3 - Budget 2017

R4 - HIV Area for Intervention: “Expanding access to HIV self-testing in low- and middle-income countries”

R5 - Area for Intervention related to Intellectual Property (IP): “Supporting the use of TRIPS flexibilities”

R6 - Appointment of the Chairs and Vice-Chairs of the standing Committees of the Board

R7 - Calendar of Unitaid Board and committee meetings for 2017

R8 - Governance Working Group

22-23 June 2016

Board Meeting 25

Hôtel de Ville and French Ministry of Foreign Affairs and International Development Paris, France.

Minutes:

Resoultions:

R1 - Unitaid audited financial statements

R2 - Amended FAC terms of reference

R3 - Policy to address risk of wrongdoing

R4 - Additional staffing requirements

R5 - Strategic option reproductive, maternal, newborn and child health

R6 - MDR-TB Strategic Rotating Stockpile (SRS) project

R7 - Potential opportunity: malaria vaccine

R8 - Unitaid’s approach to intellectual property

R9 - Terms of reference for Vice-Chair and related amendments to the board operating procedures

R10 - Election of Unitaid Executive Board Vice-Chair

R11 - Election of Unitaid Executive Board Chair

16-17 March 2016

Board Meeting 24 Special Session

Starling Hotel Geneva, Switzerland.

Minutes:

Resoultions:

R1 - Tuberculosis area for intervention: better, shorter treatments for MDR-TB

R2 - Tuberculosis area for intervention: scale up of better Tuberculosis treatment for

R3 - Tuberculosis area for intervention: enabling preventive Tuberculosis treatment in high-risk groups

R4 - Development of the 2017-2021 strategy

R5 - Selection process for the Executive Board Chair

R6 - Calendar of Unitaid board meetings for 2016

04-05 November 2015

Board Meeting 23

UNAIDS building Geneva, Switzerland.

Minutes:

Resoultions:

R10 - Review of Unitaid governance documents

R9 - Calendar of Unitaid board meetings for 2016

R8 - Term of office of the vice chair

R7 - Terms of reference and procedure for selection of new board chair

R6 - Expansion of the scope of the grant to the Medicines Patent Pool (HCV and TB)

R5 - Malaria and areas for intervention: optimizing introduction of tools for the treatment of severe malaria

R4 - Malaria and areas for intervention: expanding private sector access to diagnostics testing and treatment

R3 - Malaria and areas for intervention: accelerating adoption of innovative vector control tools

R2 - Malaria and Areas for Intervention: Expanding access to preventive chemotherapy in pregnant women

R1 - 2016 Budget

23 April 2015

EB retreat

Geneva, Switzerland.

Minutes:

Resolutions :

No resolutions adopted

02-04 June 2015

Board Meeting 22

Fiocruz’ Headquarters Rio de Janeiro, Brazil.

Minutes:

Resoultions:

R8 - MDR-TB strategic rotating stockpile (SRS) project

R7 - Market intervention to accelerate uptake of new vector control tools

R6 - Area for intervention: development of better tools to diagnose HCV, in particular in case of HIV/HCV co-infection

R5 - Area for intervention: enabling scale-up of PrEP and linkage to test

R4 - Area for intervention: improvement of adult antiretroviral therapy in low and middle-income countries

R3 - Project preparation facility

R2 - New operating model

R1 - Unitaid audited financial statements

1 2 3 4 5 6

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025

2024

January

R5-2024-e

Go-ahead for the development of grant agreement packages on Catalyzing Adoption of an Expanded Vector Control Toolbox to Fight Malaria for proposed projects with Swiss Tropical and Public Health Institute, and Centre for Research in Infectious Diseases, Cameroon

R4-2024-e

Improved Access to AHD Care and Treatment 4HIV (IMPAACT4HIV) Project

R3-2024-e

Transforming Advanced HIV Disease care in LMICs through comprehensive and equitable access (“THRIVE”) Project

R2-2024-e

Cost Extension for the Project “Integrating PrEP into Comprehensive Services for Adolescent Girls and Young Women”

R1-2024-e

Cost Extension for the Project “Advancing Spatial Repellents for Vector-borne Disease Control” (AEGIS)

2023

December

R23-2023-e

Calendar of Board and Committee meetings for 2024

R22-2023-e

Enabling Access – Medical Innovations For All

R21-2023-e

Mobilizing for Equitable Access

1 2 3 4 5 … 27

No posts found.

Sign up for Unitaid updates

First Name

Last Name

Email

Contact us

Connect

Apply for funding
Careers
Report fraud or abuse

Useful links

About Unitaid
Executive Board
Projects
Why Unitaid?

Game-changing innovations
Publications
News
Events

Email scams
Privacy policy

Follow us on social media

© World Health Organization. All rights reserved 2025. Unitaid is a hosted partnership of the World Health Organization.